Our experimental results demonstrate that upregulating a chRCC-specific TF, FOXI1, can partially reprogram a ccRCC cell line, 786-O, towards a chRCC transcriptional phenotype; consistent with results from other tumor and normal cell types showing that master TFs govern the transcriptional identity of the cell or tissue. The gene discussed is FOXI1; the disease is neoplasm.